odapipam has been researched along with raclopride in 6 studies
Studies (odapipam) | Trials (odapipam) | Recent Studies (post-2010) (odapipam) | Studies (raclopride) | Trials (raclopride) | Recent Studies (post-2010) (raclopride) |
---|---|---|---|---|---|
19 | 4 | 3 | 1,802 | 132 | 419 |
Protein | Taxonomy | odapipam (IC50) | raclopride (IC50) |
---|---|---|---|
D(2) dopamine receptor | Homo sapiens (human) | 0.052 | |
D(2) dopamine receptor | Mus musculus (house mouse) | 0.032 | |
D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 0.0279 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (66.67) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Glenthøj, B | 1 |
Gerlach, J; Lublin, H; Mørkeberg, F | 1 |
Gerlach, J; Hansen, L; Mørkeberg, F; Peacock, L | 1 |
Abi-Dargham, A; Anjilvel, S; Foged, C; Halldin, C; Hwang, DR; Kegeles, L; Laruelle, M; Lombardo, I; Mann, JJ; Parsey, R; Simpson, N; Van Heertum, R; Zea-Ponce, Y | 1 |
Aalto, S; Forssell, H; Hagelberg, N; Jääskeläinen, S; Luutonen, S; Någren, K; Rinne, JO; Scheinin, H; Taiminen, T | 1 |
Aalto, S; Eskola, O; Forssell, H; Hagelberg, N; Jääskeläinen, SK; Någren, K; Rinne, JO; Scheinin, H; Taiminen, T | 1 |
6 other study(ies) available for odapipam and raclopride
Article | Year |
---|---|
Persistent vacuous chewing in rats following neuroleptic treatment: relationship to dopaminergic and cholinergic function.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antipsychotic Agents; Apomorphine; Benzazepines; Benzofurans; Dopamine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dyskinesia, Drug-Induced; Haloperidol; Male; Parasympathetic Nervous System; Raclopride; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides; Scopolamine; Stereotyped Behavior | 1993 |
Long-term treatment with low doses of the D1 antagonist NNC 756 and the D2 antagonist raclopride in monkeys previously exposed to dopamine antagonists.
Topics: Animals; Basal Ganglia Diseases; Behavior, Animal; Benzazepines; Benzofurans; Cebus; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dyskinesia, Drug-Induced; Ergolines; Grooming; Hypnotics and Sedatives; Male; Motor Activity; Quinpirole; Raclopride; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides | 1994 |
Chronic dopamine D1, dopamine D2 and combined dopamine D1 and D2 antagonist treatment in Cebus apella monkeys: antiamphetamine effects and extrapyramidal side effects.
Topics: Amphetamine; Animals; Arousal; Basal Ganglia Diseases; Benzazepines; Benzofurans; Cebus; Dopamine Agents; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Drug Interactions; Dyskinesia, Drug-Induced; Dystonia; Male; Motor Activity; Raclopride; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides; Stereotyped Behavior | 1999 |
PET studies of binding competition between endogenous dopamine and the D1 radiotracer [11C]NNC 756.
Topics: Amphetamine; Animals; Benzazepines; Benzofurans; Binding, Competitive; Brain Chemistry; Carbon Radioisotopes; Cerebral Cortex; Corpus Striatum; Dopamine; Dopamine Agents; Dopamine Antagonists; Female; Magnetic Resonance Imaging; Male; Papio; Raclopride; Receptors, Dopamine D1; Salicylamides; Thalamus; Tomography, Emission-Computed | 1999 |
Striatal dopamine D1 and D2 receptors in burning mouth syndrome.
Topics: Adult; Aged; Benzazepines; Benzofurans; Burning Mouth Syndrome; Carbon Radioisotopes; Chronic Disease; Corpus Striatum; Dopamine Antagonists; Humans; Middle Aged; Raclopride; Receptors, Dopamine D1; Receptors, Dopamine D2; Tomography, Emission-Computed | 2003 |
Altered dopamine D2 receptor binding in atypical facial pain.
Topics: Aged; Benzazepines; Benzofurans; Carbon Radioisotopes; Dihydroxyphenylalanine; Dopamine Antagonists; Facial Pain; Humans; Middle Aged; Putamen; Raclopride; Receptors, Dopamine D1; Receptors, Dopamine D2; Tomography, Emission-Computed | 2003 |